This inventor holds 2 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignees: Azad Pharmaceutical Ingredients Ag, Saltigo Gmbh, Unversität Zürich. Active years: 2010-2011.
Location History:
- Dusseldorf, DE (2010)
- Düsseldorf, DE (2011)
Company Filing History:
1 out of 3 
1 out of 34 
1 out of 276 
Years Active: 2010-2011
Title: Mark Sundermeier: Innovator in Organic Chemistry
Introduction
Mark Sundermeier is a notable inventor based in Düsseldorf, Germany. He has made significant contributions to the field of organic chemistry, particularly in the development of processes for synthesizing complex organic compounds. With a total of 2 patents to his name, Sundermeier's work has implications for both pharmaceutical and chemical industries.
Latest Patents
Sundermeier's latest patents include a process for preparing organic compounds through a transition metal-catalyzed cross-coupling reaction. This invention focuses on functionalized aryl, heteroaryl, cycloalkenyl, or alkenyl compounds, utilizing various halides as leaving groups. Another significant patent involves the polymorphic forms of olopatadine hydrochloride, a selective histamine H1-receptor antagonist. This invention not only presents a novel polymorphic form of olopatadine but also outlines methods for its large-scale production, emphasizing cost-effectiveness and reduced impurities.
Career Highlights
Throughout his career, Sundermeier has worked with prominent companies such as Saltigo GmbH and Azad Pharmaceutical Ingredients AG. His experience in these organizations has allowed him to refine his expertise in organic synthesis and pharmaceutical development.
Collaborations
Some of his notable coworkers include Thomas Bader and Matthias Gotta. Their collaborative efforts have contributed to advancements in the field of organic chemistry.
Conclusion
Mark Sundermeier's innovative work in organic chemistry and his contributions to the development of new processes and compounds highlight his importance as an inventor. His patents reflect a commitment to advancing the field and improving pharmaceutical manufacturing methods.